April D. Lake

发表

Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease

N. Araníbar, M. Reily, D. Robertson, 2014, Amino Acids.

The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

April D. Lake, P. Novák, N. Cherrington, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

Folate receptor‐beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis

P. Low, April D. Lake, N. Cherrington, 2019, Toxicology and applied pharmacology.

Renal Xenobiotic Transporter Expression is Altered in Multiple Experimental Models of Nonalcoholic Steatohepatitis

April D. Lake, N. Cherrington, R. Hardwick, 2015, Drug Metabolism and Disposition.

Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease

A. J. Gandolfi, G. Scheffer, April D. Lake, 2012, Drug Metabolism and Disposition.

Microsoft Word-50742219-file00

April D. Lake, N. Cherrington, R. Hardwick, 2010 .

Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease

April D. Lake, N. Cherrington, R. Hardwick, 2010, Drug Metabolism and Disposition.

Metabolomic Profiling Distinction of Human Nonalcoholic Fatty Liver Disease Progression from a Common Rat Model

D. Billheimer, N. Araníbar, M. Reily, 2017, Obesity.

Synergistic interaction between genetics and disease on pravastatin disposition.

C. Klaassen, April D. Lake, N. Cherrington, 2014, Journal of hepatology.

Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver Disease

Z. Lu, A. Slitt, J. Manautou, 2013, Drug Metabolism and Disposition.

DMD048439 554..561

A. Slitt, J. Manautou, April D. Lake, 2013 .

Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.

N. Araníbar, M. Reily, D. Robertson, 2013, Toxicology and applied pharmacology.

PROGRESSIVE STAGES OF HUMAN NON-ALCOHOLIC FATTY LIVER

April D. Lake, N. Cherrington, R. Hardwick, 2010 .

Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.

S. Snyder, T. Anumol, April D. Lake, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression

April D. Lake, N. Cherrington, R. Hardwick, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Impaired N‐linked glycosylation of uptake and efflux transporters in human non‐alcoholic fatty liver disease

April D. Lake, P. Novák, N. Cherrington, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Circulating microRNA 122 in the methionine and choline‐deficient mouse model of non‐alcoholic steatohepatitis

E. Blomme, April D. Lake, N. Cherrington, 2014, Journal of applied toxicology : JAT.

Latent carcinogenicity of early-life exposure to dichloroacetic acid in mice.

S. Hester, Beena Vallanat, C. Wood, 2015, Carcinogenesis.

Development of high-yield autofluorescent protein microarrays using hybrid cell-free expression with combined Escherichia coli S30 and wheat germ extracts

D. Galbraith, April D. Lake, Xristo Zarate, 2010, Proteome Science.

Characterization of Hepatocellular Carcinoma Related Genes and Metabolites in Human Nonalcoholic Fatty Liver Disease

N. Araníbar, M. Reily, D. Robertson, 2014, Digestive Diseases and Sciences.

Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis.

April D. Lake, P. Novák, N. Cherrington, 2016, Biochemical pharmacology.

Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models

April D. Lake, N. Cherrington, R. Hardwick, 2014, Drug Metabolism and Disposition.

Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease

N. Araníbar, M. Reily, D. Robertson, 2015, Amino Acids.

Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease

D. Billheimer, April D. Lake, P. Novák, 2011, Drug Metabolism and Disposition.

Dose and Effect Thresholds for Early Key Events in a PPARα-Mediated Mode of Action.

Elaina M Kenyon, Charlene A McQueen, Virunya S Bhat, 2016, Toxicological sciences : an official journal of the Society of Toxicology.

Differential Regulation of Hepatic Organic Cation Transporter 1, Organic Anion-Transporting Polypeptide 1a4, Bile-Salt Export Pump, and Multidrug Resistance-Associated Protein 2 Transporter Expression in Lymphocyte-Deficient Mice Associates with Interleukin-6 Production

April D. Lake, N. Cherrington, A. Dzierlenga, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Renal Xenobiotic Transporter Expression is Altered in Multiple Experimental Models of Nonalcoholic Steatohepatitis

April D. Lake, N. Cherrington, A. Dzierlenga, 2015, Drug Metabolism and Disposition.

Synergistic interaction between genetics and disease on pravastatin disposition.

C. Klaassen, April D. Lake, N. Cherrington, 2014, Journal of hepatology.

Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease

D. Billheimer, April D. Lake, P. Novák, 2011, Drug Metabolism and Disposition.